Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 21

Trial Status

Recruiting1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT07724223Phase 2Recruiting
Fruquintinib Plus Anti-EGFR Antibody for Third-Line Treatment of RAS Wild-Type mCRC
Metastatic Colorectal Cancer (CRC)
PrincipalinvestigatorStart date: 2026-01-16

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Abdullah Esmail, MD

Houston Methodist Neal Cancer Center

Moderately Similar
3 trials

Shared therapeutic areas:

Metastatic Colorectal Cancer (CRC)
Similarity Score30%

Liangjun Zhu, Dr

Jiangu Cancer Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Metastatic Colorectal Cancer (CRC)
Similarity Score30%

Hannah Robinson, MD

University of Colorado, Denver

Moderately Similar
1 trials

Shared therapeutic areas:

Metastatic Colorectal Cancer (CRC)
Similarity Score30%

DEZHI LI

4th Affiliated Hospital, School of Medicine, Zhejiang University, China

Moderately Similar
1 trials

Shared therapeutic areas:

Metastatic Colorectal Cancer (CRC)
Similarity Score30%

Jean-Marc JML LIMACHER, Dr

Odimma Therapeutics

Moderately Similar
1 trials

Shared therapeutic areas:

Metastatic Colorectal Cancer (CRC)
Similarity Score30%

Maen Abdelrahim, MD, PhD, Pharm D

The Methodist Hospital Research Institute

Moderately Similar
2 trials

Shared therapeutic areas:

Metastatic Colorectal Cancer (CRC)
Similarity Score30%

Dr Julie VINCENT

Centre Georges François Leclerc

Moderately Similar
1 trials

Shared therapeutic areas:

Metastatic Colorectal Cancer (CRC)
Similarity Score30%

Namrata Vijayvergia, MD

Fox Chase Cancer Center

Moderately Similar
3 trials

Shared therapeutic areas:

Metastatic Colorectal Cancer (CRC)
Similarity Score30%

Aung Naing, Md

M.D. Anderson Cancer Center

Moderately Similar
16 trials

Shared therapeutic areas:

Metastatic Colorectal Cancer (CRC)
Similarity Score30%

Salvatore Siena, MD

ASST Niguarda Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Metastatic Colorectal Cancer (CRC)
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT07724223Phase 2PrincipalInvestigator

Fruquintinib Plus Anti-EGFR Antibody for Third-Line Treatment of RAS Wild-Type mCRC

Metastatic Colorectal Cancer (CRC)
Recruiting

All 1 trials loaded